The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pregabalin Mylan 225 mg hard capsules



Mylan Pharmaceuticals LimitedEU/1/15/997/040-044

Main Information

Trade NamePregabalin Mylan 225 mg hard capsules
Active SubstancesPregabalin
Dosage FormCapsule, hard
Licence HolderMylan Pharmaceuticals Limited
Licence NumberEU/1/15/997/040-044

Group Information

ATC CodeN03A ANTIEPILEPTICS

Status

License statusAuthorised
Licence Issued25/06/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable ListPregabalin 225mg Capsules
Interchangeable List CodeIC0110-064-001
Interchangeable List DocumentPDF of Interchangeable List
« Back